d0lphint0m Saturday, 05/23/20 02:50:20 PM Re: hopester post# 79761 Post # of 82065 I have noticed that your posts appear to reflect a less than optimistic perspective toward CYDY while having an optimistic view of PSTI. Perhaps your perspectives are based on market cap alone. Certainly the charts are very similar but the prospects for Leronlimab you must admit are quite astonishing and the market cap is extremely under valued if the science continues to show the results that it has. I do agree with you that money is and always has been a challenge for all biotech companies but the obstacle is much less of a concern with the company now then it was 3 months ago. If they were to announce a desire to increase AS the initial reaction would be for the shorts to beat their drums but I anticipate that the reaction would be less reactive then they wished in time and in it's reaction to price.